Remote Monitoring for Gestational Diabetes Management

iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes

Recruiting N/A Interventional Study
Gestational Diabetes Type2 Diabetes Pregnancy in Diabetic
Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Diagnostic
Participants needed
200 (estimated)
Sponsor
The University of Texas Health Science Center, Houston · Other
Who this trial is looking for

This trial is looking for women who are 18 years or older and have gestational diabetes or type 2 diabetes during pregnancy. Participants will track their blood sugar levels using a special remote monitoring device to see if it helps manage their condition better.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a woman aged 18 or older.
  • I have gestational diabetes or type 2 diabetes during pregnancy.
  • I was identified and consented before 30.6 weeks of pregnancy.
  • I have a single healthy baby.

You may not be able to join if

  • I have type 1 diabetes.
  • My baby has major congenital abnormalities.
  • I was identified after 30.6 weeks of pregnancy.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria * All patients \>/= women 18 years of age with gestational diabetes or type 2 diabetes during pregnancy and identified by the research team and consented before 30.6 weeks. * Non-anomalous singletons * Ability to provide informed consent Exclusion Criteria * Patients with Type …
Contacts

Joycelyn Corthwaite, RD

832-325-7205

joycelyn.a.cornthwaite@uth.tmc.edu

CONTACT

Clara Ward, MD

713-500-6412

clara.ward@uth.tmc.edu

CONTACT